Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

DE-104 ophthalmic solution completed a Phase 2 safety and efficacy study in open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-104 ophthalmic solution (DE-104)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED